Article
Gene Editing for the Treatment of Primary Immunodeficiency Diseases
16 Sept 2020
Abstract excerpt
With conventional treatments for primary immunodeficiency diseases (PIDs), such as allogeneic stem cell transplantation or autologous gene therapy, still facing important challenges, the rapid development of genome editing technologies to more accurately correct the mutations underlying the onset of genetic disorders has provided a new alternative, yet promising platform for the treatment of such diseases. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
